JAMA Editors' Summary

Ivermectin for Mild to Moderate COVID-19, Persistent Symptoms Following COVID-19, Review of Hypercalcemia, and more

10.25.2022 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Editors' Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 25, 2022, issue.

More episodes from JAMA Editors' Summary